RIGL CIK: 1034842

Rigel Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.88
FY22:
−73.8
FY23:
−5.74
FY24:
31.5
FY25:
75.7
Change from FY21 to FY25
millions USD
FY21:
−80.0
FY22:
72.8
FY23:
−4.30
FY24:
4.13
FY25:
−92.4
Change from FY21 to FY25
millions USD
FY21:
62.7
FY22:
6.55
FY23:
18.4
FY24:
−11.6
FY25:
0.60
(positive)
Change from FY21 to FY22
millions USD
FY21:
5.25
FY22:
−74.2
FY23:
–
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR